ReviewCrit Rev Oncol Hematol2026
Harnessing the effector-to-regulatory T cell ratio to advance prognosis and precision therapy in pancreatic cancer.
- Journal
- Crit Rev Oncol Hematol
- Published
- 9 December 2025
- Citations
- 3
- Type
- Review
- License
- cc by
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try